Parker Geoffrey M.

CIK 00014918749 companiesCARLSBAD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001491874

Recent Transactions

50 trades

Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2025-12-12+2,140→ 2,140 total
Purchase
PERRIGO Co plc$PRGO
Ordinary Shares
2025-11-12$14.18/sh+7,500→ 17,375 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-10-21$1.26/sh−36,744→ 1,276,796 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2025-09-12+1,263→ 1,263 total
Purchase
PERRIGO Co plc$PRGO
Ordinary Shares
2025-08-18$22.97/sh+4,375→ 33,287 total
Purchase
PERRIGO Co plc$PRGO
Ordinary Shares
2025-08-18$22.97/sh+4,375→ 9,875 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2025-06-13+976→ 976 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2025-05-14$26.01/sh−4,754→ 28,912 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2025-05-14+7,305→ 7,305 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2025-05-14−9,904→ 0 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2025-05-14$26.01/sh+9,904→ 33,666 total
Purchase
PERRIGO Co plc$PRGO
Ordinary Shares
2025-05-12$27.10/sh+3,500→ 23,762 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-02-03$1.73/sh−4,361→ 1,301,540 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2025-01-24+614,844→ 614,844 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-01-24+173,913→ 1,305,901 total
Tax Payment
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-10-21$2.84/sh−36,404→ 1,131,988 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-05-16$2.90/sh+344,828→ 1,164,418 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2024-05-15$30.22/sh+8,764→ 24,469 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2024-05-15−8,764→ 0 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2024-05-15$30.22/sh−4,207→ 20,262 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2024-05-14+9,904→ 9,904 total
Purchase
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-01-30$3.60/sh+190→ 819,590 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-01-25+103,939→ 103,939 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-01-25+29,400→ 819,400 total
Award
Better Therapeutics, Inc.
Common Stock
2023-12-18+3,750→ 1,031,805 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-10-16+390,000→ 790,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-10-16+400,000→ 400,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-10-16+950,000→ 950,000 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-07-27$0.73/sh+685,025→ 1,028,055 total
Purchase
PERRIGO Co plc$PRGO
Ordinary Shares
2023-06-13$33.06/sh+10,000→ 25,879 total
Award
Better Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-07+15,000→ 15,000 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2023-05-17$32.86/sh+7,778→ 19,439 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2023-05-17−7,778→ 0 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2023-05-17$32.86/sh−3,734→ 15,705 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2023-05-15+8,764→ 8,764 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-04-10$0.82/sh+303,030→ 343,030 total
Purchase
PERRIGO Co plc$PRGO
Ordinary Shares
2023-03-06$38.05/sh+5,000→ 15,879 total
Disposition to Issuer
ChemoCentryx, Inc.
Restricted Stock Unit
2022-10-20−15,723→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−13,352→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Common Stock
2022-10-20−21,076→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−12,500→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−8,342→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Common Stock
2022-10-20−5,000→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−12,287→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−4,504→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Common Stock
2022-10-20−107,997→ 0 total
Purchase
Better Therapeutics, Inc.
Common Stock
2022-06-13$1.45/sh+25,000→ 40,000 total
Award
Better Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09+15,000→ 15,000 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2022-05-26+8,342→ 8,342 total
Award
ChemoCentryx, Inc.
Restricted Stock Units
2022-05-26+15,723→ 15,723 total

Companies

Recent Filings

Address

C/O GENOPTIX, INC., 1811 ASTON AVENUE

CARLSBAD, CA, 92008

View on SEC.gov